Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma

  1. Fust, K.
  2. Li, X.
  3. Maschio, M.
  4. Villa, G.
  5. Parthan, A.
  6. Barron, R.
  7. Weinstein, M.C.
  8. Somers, L.
  9. Hoefkens, C.
  10. Lyman, G.H.
Aldizkaria:
PharmacoEconomics

ISSN: 1179-2027,  1170-7690

Argitalpen urtea: 2017

Alea: 35

Zenbakia: 4

Orrialdeak: 425-438

Mota: Artikulua

DOI: 10.1007/S40273-016-0474-0 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus